138
Views
14
CrossRef citations to date
0
Altmetric
Original Research

Lumbrokinase/paclitaxel nanoparticle complex: potential therapeutic applications in bladder cancer

, , , , , & show all
Pages 3625-3640 | Published online: 26 Jun 2018

References

  • SiegelRMaJZouZJemalACancer statistics, 2014CA Cancer J Clin201464192924399786
  • PloegMAbenKKKiemeneyLAThe present and future burden of urinary bladder cancer in the worldWorld J Urol200927328929319219610
  • DuMShiDYuanLCirculating miR-497 and miR-663b in plasma are potential novel biomarkers for bladder cancerSci Rep201551043726014226
  • El-AshmawyNEKhedrEGEl-BahrawyHAAl-TantawySMChemopreventive effect of omega-3 polyunsaturated fatty acids and atorvastatin in rats with bladder cancerTumour Biol2017392 1010428317692254
  • SiegelRNaishadhamDJemalACancer statistics, 2013CA Cancer J Clin2013631113023335087
  • PanZJDengNZouZHChenGXThe effect of curcumin on bladder tumor in rat modelEur Rev Med Pharmacol Sci201721488488928272691
  • JemalABrayFCenterMMFerlayJWardEFormanDGlobal cancer statisticsCA Cancer J Clin2011612699021296855
  • BlaveriESimkoJPKorkolaJEBladder cancer outcome and subtype classification by gene expressionClin Cancer Res200511114044405515930339
  • SuganoKKakizoeTGenetic alterations in bladder cancer and their clinical applications in molecular tumor stagingNat Clin Pract Urol200631264265217149381
  • KnowlesMAMolecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese?Carcinogenesis200627336137316352616
  • BabjukMBohleABurgerMEAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016Eur Urol201771344746127324428
  • WirthMPlattnerVEGaborFStrategies to improve drug delivery in bladder cancer therapyExpert Opin Drug Deliv20096772774419538035
  • KanemotoKFukutaKKawaiNGenomic landscape of experimental bladder cancer in rodents and its application to human bladder cancer: gene amplification and potential overexpression of Cyp2a5/CYP2A6 are associated with the invasive phenotypePLoS One20161111e016737427902773
  • MansoorMAliSFasihuddinQBalochMUSuperficial bladder tumours: recurrence and progressionJ Coll Physicians Surg Pak201121315716021419022
  • PasinEJosephsonDYMitraAPCoteRJSteinJPSuperficial bladder cancer: an update on etiology, molecular development, classification, and natural historyRev Urol2008101314318470273
  • HerrHWHigh-risk superficial bladder cancer: transurethral resection alone in selected patients with T1 tumorSemin Urol Oncol19971531421469394908
  • LiuJDuanXPA-MSHA induces apoptosis and suppresses metastasis by tumor associated macrophages in bladder cancer cellsCancer Cell Int2017177628824336
  • ChenNCChyauCCLeeYJTsengHCChouFPPromotion of mitotic catastrophe via activation of PTEN by paclitaxel with supplement of mulberry water extract in bladder cancer cellsSci Rep201662041726838546
  • ZhangXWuYZhangMSodium cholateenhanced polymeric micelle system for tumor-targeting delivery of paclitaxelInt J Nanomedicine2017128779879929263668
  • WuCXuJHaoYApplication of a lipid-coated hollow calcium phosphate nanoparticle in synergistic co-delivery of doxorubicin and paclitaxel for the treatment of human lung cancer A549 cellsInt J Nanomedicine2017127979799229184399
  • ZhouMLiXLiYAscorbyl palmitate-incorporated paclitaxel-loaded composite nanoparticles for synergistic anti-tumoral therapyDrug Deliv20172411230124228856937
  • ChenHTakahashiSImamuraMEarthworm fibrinolytic enzyme: anti-tumor activity on human hepatoma cells in vitro and in vivoChin Med J (Engl)20071201089890417543180
  • TjandrawinataRRYunaidiDASusantoLWThe safety and tolerability of lumbrokinase DLBS1033 in healthy adult subjectsDrug Res (Stuttg)201666629329927011386
  • JiangGZhangWPengMYanWEffect of lumbrokinase on patients with acute and moderate risk pulmonary thromboembolismZhong Nan Da Xue Xue Bao Yi Xue Ban2017421011561162 Chinese29093246
  • RyuGHParkSKimMHanDKKimYHMinBAntithrombogenicity of lumbrokinase-immobilized polyurethaneJ Biomed Mater Res1994289106910777814434
  • AlyafeeYAAlaameryMBawazeerSPreparation of anastrozole loaded PEG-PLA nanoparticles: evaluation of apoptotic response of breast cancer cell linesInt J Nanomedicine20181319920829343958
  • HouseholderKTDiPernaDMChungEPpH driven precipitation of quisinostat onto PLA-PEG nanoparticles enables treatment of intracranial glioblastomaColloids Surf B Biointerfaces2018166374429533842
  • FichtnerMClausCLessig-OwlanjJArnholdJReibetanzUThe application of LbL-microcarriers for the treatment of chronic inflammation: monitoring the impact of LbL-microcarriers on cell viabilityMacromol Biosci201515454655725565138
  • XuGGuHHuBPEG-b-(PELG-g-PLL) nanoparticles as TNF-alpha nanocarriers: potential cerebral ischemia/reperfusion injury therapeutic applicationsInt J Nanomedicine2017122243225428356740
  • TongFZhangHPoly (Ethylene Glycol)-Block-Brush Poly (L-Lysine) copolymer as an efficient nanocarrier for human hepatocyte growth factor with enhanced bioavailability and anti-ischemia reperfusion injury efficacyKidney Blood Press Res201742349550828854424
  • TongFTangXLuoLSustained delivery of insulin-loaded block copolymers: potential implications on renal ischemia/reperfusion injury in diabetes mellitusBiomed Pharmacother20179153454528482291
  • TongFPreparation of exenatide-loaded linear poly(ethylene glycol)-brush poly(l-lysine) block copolymer: potential implications on diabetic nephropathyInt J Nanomedicine2017124663467828721043
  • TongFTangXLiXXiaWLiuDThe effect of insulin-loaded linear poly(ethylene glycol)-brush-like poly(l-lysine) block copolymer on renal ischemia/reperfusion-induced lung injury through downregulating hypoxia-inducible factorInt J Nanomedicine2016111717173027175073
  • LammDLBCG in perspective: advances in the treatment of superficial bladder cancerEur Urol199527Suppl 1287750528
  • TsujiSChenXHancockBPreclinical evaluation of VAX-IP, a novel bacterial minicell-based biopharmaceutical for nonmuscle invasive bladder cancerMol Ther Oncolytics201631600427119118
  • McKiernanJMHolderDDGhandourRAPhase II trial of intravesical nanoparticle albumin bound paclitaxel for the treatment of nonmuscle invasive urothelial carcinoma of the bladder after bacillus Calmette-Guerin treatment failureJ Urol201419261633163824996128
  • MontironiRChengLScarpelliMLopez-BeltranAPathology and genetics: tumours of the urinary system and male genital system: clinical implications of the 4th edition of the WHO classification and beyondEur Urol201670112012326996660
  • GuoSXuPZhouAContrast-enhanced ultrasound differentiation between low- and high-grade bladder urothelial carcinoma and correlation with tumor microvessel densityJ Ultrasound Med201736112287229728556470
  • HuangJMaXChenXMicrovessel density as a prognostic factor in bladder cancer: a systematic review of literature and meta-analysisCancer Biomark201414650551425335742
  • PustylnyakVOLisachevPDShtarkMBExpression of p53 target genes in the early phase of long-term potentiation in the rat hippocampal CA1 areaNeural Plast2015201524215825767724
  • Ben Ya’acovAMeirHZolotaryovaLIlanYShteyerEImpaired liver regeneration is associated with reduced cyclin B1 in natural killer T cell-deficient miceBMC Gastroenterol20171714428330461
  • HuBWuYLiuJGSK-3beta inhibitor induces expression of Nrf2/TrxR2 signaling pathway to protect against renal ischemia/reperfusion injury in diabetic ratsKidney Blood Press Res201641693794627924803
  • LeopardoDCecereSCDi NapoliMIntravesical chemo-immunotherapy in non muscle invasive bladder cancerEur Rev Med Pharmacol Sci201317162145215823893180
  • SindhwaniPHamptonJABaigMMKeckRSelmanSHCurcumin prevents intravesical tumor implantation of the MBT-2 tumor cell line in C3H miceJ Urol200116641498150111547120
  • JaganathanAMuruganKPanneerselvamCEarthworm-mediated synthesis of silver nanoparticles: a potent tool against hepatocellular carcinoma, plasmodium falciparum parasites and malaria mosquitoesParasitol Int201665327628426873539
  • CooperELRuBWengNEarthworms: sources of antimicrobial and anticancer moleculesAdv Exp Med Biol200454635938915584386
  • VillePRochPCooperELMassonPNarbonneJFPCBs increase molecular-related activities (lysozyme, antibacterial, hemolysis, pro-teases) but inhibit macrophage-related functions (phagocytosis, wound healing) in earthwormsJ Invertebr Pathol19956532172247745278
  • KasimMKiatAARohmanMSHanifahYKiatHImproved myocardial perfusion in stable angina pectoris by oral lumbrokinase: a pilot studyJ Altern Complement Med200915553954419416019
  • PeltierSOgerJMLagarceFCouetWBenoitJPEnhanced oral paclitaxel bioavailability after administration of paclitaxel-loaded lipid nanocapsulesPharm Res20062361243125016715372
  • ParayathNNNehoffHNortonSEStyrene maleic acid-encapsulated paclitaxel micelles: antitumor activity and toxicity studies following oral administration in a murine orthotopic colon cancer modelInt J Nanomedicine2016113979399127574427
  • BerveillerPMirOTaxanes during pregnancy: probably safe, but still to be optimizedOncology201283423924022907122
  • PepeDCarvalhoVFMcCallMde LemosDPLopesLBTransportan in nanocarriers improves skin localization and antitumor activity of paclitaxelInt J Nanomedicine2016112009201927274232